» Authors » Johan Verbraecken

Johan Verbraecken

Explore the profile of Johan Verbraecken including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 133
Citations 2632
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Oost N, Masci F, Schyvens A, Peters B, Dirix H, Ross V, et al.
Annu Int Conf IEEE Eng Med Biol Soc . 2025 Mar; 2024:1-4. PMID: 40040179
The shortage of drivers in Europe is at its worst level in decades. One aspect in addressing this issue is improving driver health in this demanding profession. A sustainable solution...
2.
Mendoza Alvarez M, Balthasar Y, Verbraecken J, Claes L, van Someren E, van Marle H, et al.
Sleep Med . 2025 Jan; 127:1-15. PMID: 39756154
Background: Fragmented rapid eye movement (REM) sleep disrupts the overnight resolution of emotional distress, a process crucial for emotion regulation. Emotion dysregulation, which is common across psychiatric disorders, is often...
3.
Massie F, Vits S, Verbraecken J, Bergmann J
J Clin Sleep Med . 2025 Jan; PMID: 39748512
Study Objectives: Home sleep apnea testing based on peripheral arterial tonometry (P-HSAT) is increasingly being deployed because of its ability to test for multiple nights. However, P-HSATs do not have...
4.
Matthes S, Treml M, Grote L, Hedner J, Zou D, Bonsignore M, et al.
Eur Respir J . 2024 Oct; 64(6). PMID: 39481866
Background: The "Baveno classification" replaced the apnoea-hypopnoea index (AHI) with symptoms and comorbidities for treatment indication in obstructive sleep apnoea (OSA). This study evaluates a modified Baveno classification which adds...
5.
Massie F, Vits S, Verbraecken J, Bergmann J
Sleep . 2024 Oct; PMID: 39441980
Study Objectives: This paper reports on the clinical evaluation of the sleep staging performance of a novel single-lead biopotential device. Methods: 133 patients suspected of obstructive sleep apnea were included...
6.
Dauvilliers Y, Craig S, Bonsignore M, Barbe F, Verbraecken J, Asin J, et al.
J Sleep Res . 2024 Oct; :e14373. PMID: 39377364
Obstructive sleep apnea (OSA) syndrome commonly leads to excessive daytime sleepiness (EDS). Pitolisant, a selective histamine-3 receptor antagonist, is efficacious at doses up to 20 mg once daily in OSA...
7.
Pepin J, Lehert P, Ben Messaoud R, Joyeux-Faure M, Causse C, Asin J, et al.
EClinicalMedicine . 2024 Sep; 76:102843. PMID: 39346006
Background: Obstructive sleep apnoea (OSA) is a common chronic respiratory disease associated with a high burden of disabilities related to sleepiness and reduced quality of life. Despite first-line treatment with...
8.
Tukanov E, Van Loo D, Dieltjens M, Verbraecken J, Vanderveken O, Op de Beeck S
Life (Basel) . 2024 Sep; 14(9). PMID: 39337912
Hypoglossal nerve stimulation (HGNS) has emerged as an effective treatment for obstructive sleep apnea (OSA). Identifying baseline characteristics that prospectively could predict treatment outcomes even better is crucial for optimizing...
9.
Van Daele M, Smolders Y, Van Loo D, Bultynck C, Verbraecken J, Vroegop A, et al.
Life (Basel) . 2024 Aug; 14(8). PMID: 39202749
Obstructive sleep apnea (OSA) is a sleep disorder characterized by repetitive episodes of partial or complete obstruction of the upper airway during sleep. Continuous positive airway pressure (CPAP) is a...
10.
Hellemans S, Van de Perck E, Van Loo D, Verbraecken J, Sands S, Azarbarzin A, et al.
Life (Basel) . 2024 Aug; 14(8). PMID: 39202705
Surgical interventions, like barbed reposition pharyngoplasty (BRP), are a valuable alternative for patients with obstructive sleep apnea (OSA) who are unable to tolerate continuous positive airway pressure (CPAP). However, predicting...